However, alterations in ERBB2, MET, PIK3CA, PTEN and HRAS can co-occur with EGFR alterations and may explain mechanisms of EGFR inhibitor resistance in individual HNSCC [14]. The gene discussed is HRAS; the disease is head and neck squamous cell carcinoma.